Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8691723 | World Neurosurgery | 2018 | 19 Pages |
Abstract
It is important for neurosurgeons to be aware of this rare entity. The treatment protocol remains controversial and is primarily guided by expert opinion. It is important to aggressively treat the patient with antibiotics followed by adjuvant therapy for malignancy. The timing and administration of adjuvant therapy are unclear. We suggest a delay of chemotherapy until at least 4 weeks of therapy with sensitive antibiotics.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Kislay Kishore, Manish Beniwal, Shilpa Rao, K.V.L. Narasinga Rao, Vikas Vazhayil, Dwarakanath Srinivas, Sampath Somanna,